1. Home
  2. STXS vs PMI Comparison

STXS vs PMI Comparison

Compare STXS & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

HOLD

Current Price

$2.55

Market Cap

210.0M

Sector

Health Care

ML Signal

HOLD

PMI

Picard Medical Inc.

N/A

Current Price

$1.73

Market Cap

202.7M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
STXS
PMI
Founded
1990
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
210.0M
202.7M
IPO Year
2004
2025

Fundamental Metrics

Financial Performance
Metric
STXS
PMI
Price
$2.55
$1.73
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
388.9K
634.0K
Earning Date
11-11-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$30,075,000.00
$4,767,000.00
Revenue This Year
$24.21
N/A
Revenue Next Year
$29.83
N/A
P/E Ratio
N/A
N/A
Revenue Growth
19.62
8.81
52 Week Low
$1.54
$1.65
52 Week High
$3.59
$13.68

Technical Indicators

Market Signals
Indicator
STXS
PMI
Relative Strength Index (RSI) 60.40 N/A
Support Level $2.25 N/A
Resistance Level $2.48 N/A
Average True Range (ATR) 0.10 0.00
MACD 0.02 0.00
Stochastic Oscillator 63.34 0.00

Price Performance

Historical Comparison
STXS
PMI

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About PMI Picard Medical Inc.

Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.

Share on Social Networks: